SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-22-006746
Filing Date
2022-04-29
Accepted
2022-04-29 17:03:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A janx_defa14a_2022.htm DEFA14A 29006
2 GRAPHIC img201241913_0.jpg GRAPHIC 1513152
3 GRAPHIC img201241913_1.jpg GRAPHIC 137589
  Complete submission text file 0000950170-22-006746.txt   2301926
Mailing Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037
Business Address 11099 TORREY PINES PARK ROAD SAN DIEGO CA 92037 858-750-4700
Janux Therapeutics, Inc. (Filer) CIK: 0001817713 (see all company filings)

IRS No.: 822289112 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40475 | Film No.: 22877184
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences